Quantum BioPharma Ltd. (QNTM)

CA — Healthcare Sector
Peers: RVPH  ANVS  CPIX  PYPD  RMTI  RNTX  CELU  BCAB  ATNM  EVAX 

Automate Your Wheel Strategy on QNTM

With Tiblio's Option Bot, you can configure your own wheel strategy including QNTM - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol QNTM
  • Rev/Share 0.0
  • Book/Share 1.9749
  • PB 1.8628
  • Debt/Equity 0.2955
  • CurrentRatio 1.4057
  • ROIC -1.9118

 

  • MktCap 16294044.0
  • FreeCF/Share -2.3065
  • PFCF -1.8585
  • PE -0.5653
  • Debt/Assets 0.1807
  • DivYield 0
  • ROE -3.8488

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 4
  • P/B Score 1
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies
QNTM
Published: March 20, 2025 by: GlobeNewsWire
Sentiment: Neutral

TORONTO, March 20, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce that after receiving approval from the Board of Directors, the Company has purchased an additional USD $1,500,000 worth of Bitcoin (BTC) and other cryptocurrencies, growing and increasing its crypto assets as part of its strategic efforts. This brings the total amount of Bitcoin (BTC), and other cryptocurrencies purchased to USD $3,500,000. As previously announced, the company will continue to allow for future financings and other transactions to be carried out in cryptocurrency.

Read More
image for news Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies

About Quantum BioPharma Ltd. (QNTM)

  • IPO Date
  • Website https://www.quantumbiopharma.com
  • Industry Drug Manufacturers - Specialty & Generic
  • CEO Zeeshan Saeed
  • Employees None

Quantum BioPharma Ltd., a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd., is headquartered in Toronto, Canada.